comparemela.com

Latest Breaking News On - Finsen laboratory - Page 1 : comparemela.com

Adcendo ApS to Present Data on its Novel ADC Target uPARAP in Glioblastoma Multiforme at the American Association for Cancer Research Annual Meeting 2

Data demonstrate that uPARAP is highly expressed in tumor samples obtained from glioblastoma multiforme patientsuPARAP targeting ADC shows cytotoxicity in glioblastoma multiforme cancer cells in vitro and exhibits potent in vivo anti-tumor activity in a glioblastoma multiforme PDX modelData provides evidence that uP.

Adcendo ApS to Present Data on its Novel ADC Target uPARAP in Glioblastoma Multiforme at the American Association for Cancer Research Annual Meeting 2024

Adcendo Appoints Dominik Mumberg, PhD, as Chief Scientific Officer

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.